Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.
Saved in:
| Title: | Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer. |
|---|---|
| Authors: | Denault E; Massachusetts General Hospital, Boston, MA, USA., Nakajima E; Massachusetts General Hospital, Boston, MA, USA., Naranbhai V; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Hutchinson JA; Massachusetts General Hospital, Boston, MA, USA., Mortensen L; Massachusetts General Hospital, Boston, MA, USA., Neihoff E; Massachusetts General Hospital, Boston, MA, USA., Barabell C; Massachusetts General Hospital, Boston, MA, USA., Comander A; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Juric D; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kuter I; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mulvey T; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Peppercorn J; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Rosenstock AS; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Shin J; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Vidula N; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Wander SA; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Moy B; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ellisen LW; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Isakoff SJ; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Iafrate AJ; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Gainor JF; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Bardia A; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Spring LM; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Aug 22; Vol. 14, pp. 17588359221119370. Date of Electronic Publication: 2022 Aug 22 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
